We provide you with 20 years of free, institutional-grade data for VIGL stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VIGL. Explore the full financial landscape of VIGL stock.
| Reported Date | CIK | Ticker | Type |
|---|
Vigil Neuroscience, Inc.(NASDAQ:VIGL) 
Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, t...
Website: https://www.vigilneuro.com
Founded: 2020
IPO Price: $14 (Jan 07, 2022)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about VIGL stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.